针刀经筋层整体松解治疗第三腰椎横突综合征临床的研究.docVIP

针刀经筋层整体松解治疗第三腰椎横突综合征临床的研究.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
针刀经筋层整体松解治疗第三腰椎横突综合征临床的研究

针刀经筋层整体松解治疗第三腰椎横突综合征临床的研究   摘要:目的 观察针刀经筋层整体松解治疗第三腰椎横突综合征(TLTPS)临床疗效。方法 采用随机数字表法将66例TLTPS患者分为试验组和对照组各33例。于患者L3棘突旁开3 cm寻找压痛点,对照组采用L3横突压痛点针刀松解,试验组在对照组基础上予针刀经筋层整体松解,均治疗1次。观察2组治疗前后及治疗后1、2、3个月患者视觉模拟评分(VAS)、Oswestry功能障碍指数(ODI),评价临床疗效,观察不良反应及并发症。结果 试验组、对照组分别脱落1、2例。与本组治疗前比较,2组治疗后各时点VAS、ODI均明显降低(P0.05)。试验组治疗后各时点VAS、ODI低于对照组,2组比较差异有统计学意义(P0.05)。试验组总有效率为96.88%(31/32),对照组为93.55%(29/31),试验组优于对照组(Z=-2.756,P=0.006)。2组均无不良反应及并发症。结论 针刀经筋层整体松解联合L3横突压痛点针刀松解可显著提高TLTPS患者临床疗效,作用持久。   关键词:第三腰椎横突综合征;针刀;经筋层松解术   DOI:10.3969/j.issn.1005-5304.2018.03.007   中图分类号:R274.915.33 文献标识码:A 文章编号:1005-5304(2018)03-0030-04   Abstract: Objective To observe the clinical efficacy of tendons layer overall release treatment by needle knife for the third lumbar transverse process syndrome (TLTPS). Methods Totally 66 cases of TLTPS patients were divided into control group and experimental groups by using random number table method, with 33 cases in each group. L3 spinous process opened 3 cm looking for tenderness. Control group received lumbar transverse pressure tender point knife release treatment. On the basis of control group, experimental group received tendons layer overall release treatment by needle knife. Both control group and experimental group received treatment once. VAS and ODI before treatment and after treatment of 1, 2 and 3 months were observed. Clinical efficacy was evaluated. Adverse reactions and complications were observed. Results The experimental group and control group lost 1 and 2 cases, respectively. Compared with before treatment, the VAS and ODI in both groups after treatment decreased (P0.05). After treatment, the VAS and ODI in the experimental group were lower than those of the control group, with statistical significance (P0.05). The total effective rate of clinical efficacy was 96.88% (31/32) in the experimental group and 93.55% (29/31) in the control group, with experimental group better than the control group (Z=-2.756, P=0.006). There were no adverse reactions or compl

文档评论(0)

3471161553 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档